Home Antibody All anti-FANCA antibodies
Also for FANCA (NM_000135)
|Recombinant fragment corresponding to a region within amino acids 1 and 220 of FANCA (Uniprot ID#O15360)|
|WB, IHC, IF
||ICC/IF:1:100-1:1000; IHC:1:100-1:1000; WB:1:500-1:3000
|0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.|
|Purified by antigen-affinity chromatography.
|Homo sapiens Fanconi anemia, complementation group A (FANCA), transcript variant 1|
|FA; FA-H; FA1; FAA; FACA; FAH; FANCH|
Entrez Gene 2175 Human
|The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq]|
|Druggable Genome |
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Sample (30 ug of whole cell lysate). A: A431 . B: Hela. 12% SDS PAGE. TA308599 diluted at 1:1000.
Immunohistochemical analysis of paraffin-embedded OV90 xenograft, using FACA(TA308599) antibody at 1:500 dilution.
Immunofluorescence analysis of paraformaldehyde-fixed HeLa, using FACA(TA308599) antibody at 1:200 dilution.